Last reviewed · How we verify
NCT06166225
Strategies for Improving Remote-based Weight Loss (PATH Trial)
NA trial testing Internet-based weight loss program in Obesity in 210 participants. Currently enrolling.
30 March 2028
Quick facts
| Lead sponsor | The Miriam Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 210 |
| Start date | 8 January 2024 |
| Primary completion | 30 March 2028 |
| Estimated completion | 30 March 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Internet-based weight loss program
- Yoga
- Health and Wellness
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
The Miriam Hospital
Who can join
Adults 18 to 65, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to examine whether the addition of online yoga classes, compared to health and wellness classes, can improve the amount of weight loss produced from an Internet-based weight loss program. All individuals will receive a 12-month, automated Internet-based weight loss program. Following 3 months of of weight loss treatment, individuals will be randomized to also receive yoga classes or health and wellness classes for 9 months. Assessments will occur at baseline, 3, 6, 12, and 18 months and will include measures of weight, eating behaviors, physical activity, and psychosocial factors.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
PATH Trial for Examining Yoga as a Strategy to Improve Remote-Based Weight Loss in Adults: Protocol for a Randomized Controlled Trial.
Tobin SY, Sherman S, Bock B, Dunsiger S, et al · · 2026 · PMID 41740089 · DOI 10.2196/78973
Verify or expand the search:
- PubMed search for NCT06166225
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Internet-based weight loss program
Trials testing the same drug.
- NCT03867981 — Phone Coaching and Internet-delivered Weight Loss · NA · completed
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other The Miriam Hospital trials
Trials by the same sponsor.
- NCT07228130 — Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment · NA · recruiting
- NCT07363616 — Pilot Test of Five Weight Neutral Interventions to Improve Health Among Adults of Higher Body Weight · NA · recruiting
- NCT06494488 — Differential Thrombogenesis by EPA and DHA Mediated by HDL · EARLY_PHASE1 · recruiting
- NCT06878872 — Type 1 Diabetes Adolescents for Healthier Lifestyles Study · NA · not yet recruiting
- NCT06875622 — Remote Approaches for Optimizing Weight Loss (Elevate Weight Loss Trial) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06166225 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Miriam Hospital
- Last refreshed: 8 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06166225.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing